Immunoinformatics-driven multi-epitope vaccine design against junin virus using whole-proteome analysis and immune simulation
In Silico Research in Biomedicine · 2026 · 2 · 100715
DOI: 10.1016/j.insi.2026.100715 ↗Kurz gefasst
Fachartikel in der Zeitschrift In Silico Research in Biomedicine, 2026. Verfasst von Md. Rakibul Hasan und 7 weiteren Autor:innen. Die Arbeit nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Junin virus (JUNV) is a causative agent of Argentine haemorrhagic fever (AHF) in humans (especially in farmers) with no long-term approved antiviral therapeutics. We developed a multi-epitope vaccine against JUNV using an immunoinformatics approach comprising sequence retrieval, epitope prediction, vaccine design and analysis, molecular docking, molecular dynamics (MD) simulations, immune simulation, and in silico cloning. Moreover, we evaluated six Cytotoxic T-Lymphocytes (CTL), four Helper T-Lymphocytes (HTL), and four Linear B-Lymphocytes (LBL) potential epitopes with high antigenicity, no allergenicity, outside membrane, and no toxicity. The vaccine was linked by β-defensin 3 and a PADRE sequence at both termini and multiple structural linkers (M, EAAAK, TAT, SSL, GGGS, GGGGS, KK) to ensure stability and proper epitope spacing. The designed vaccine showed a worldwide population coverage (98.83%), antigenic (0.8295), non-allergenic, outside membrane, and non-toxic. Additionally, structural assessment showed an ERRAT score of 94.758%, with 93.8% residues in the favored region of the Ramachandran plot and a ProSA Z-score of −6.3. Additionally, molecular docking reveals the vaccine’s favorable predicted binding affinity score with human TLR2 (−194.2) than human TLR4 (−125.5 ± 2.6), whereas MD simulation with 100 ns indicates stable behavior both structural dynamic complexes. Finally, immune simulation predicted enhanced humoral and cellular responses, with peak IFN-γ and IL-4 concentrations of approximately 400,000 and 120,000 ng/mL, respectively, while in silico cloning indicated favorable predicted expression feasibility in Escherichia coli expression of the vaccine. Furthermore, the vaccine shows potential immunity against JUNV, whether in vitro or in vivo studies are necessary to confirm its efficacy.
Zitieren
APA
Hasan, M. R., Islam, N., Roy, P. S., Falguni, S. K., Islam, E., Rayhan, M. A., Hossain, H., & Mashrur, M. N. (2026). Immunoinformatics-driven multi-epitope vaccine design against junin virus using whole-proteome analysis and immune simulation. In Silico Research in Biomedicine, 2, 100715. https://doi.org/10.1016/j.insi.2026.100715
Vancouver
Hasan MR, Islam N, Roy PS, Falguni SK, Islam E, Rayhan MA, et al. Immunoinformatics-driven multi-epitope vaccine design against junin virus using whole-proteome analysis and immune simulation. In Silico Research in Biomedicine. 2026;2:100715. doi:10.1016/j.insi.2026.100715
BibTeX
@article{Hasan2026,
author = {Hasan, Md. Rakibul and Islam, Naeem and Roy, Pritom Saha and Falguni, Saila Kabir and Islam, Ehsanul and Rayhan, Md. Abu and Hossain, Hemayet and Mashrur, Md. Nafij},
title = {Immunoinformatics-driven multi-epitope vaccine design against junin virus using whole-proteome analysis and immune simulation},
journal = {In Silico Research in Biomedicine},
year = {2026},
volume = {2},
pages = {100715},
doi = {10.1016/j.insi.2026.100715}
}
EUVIMED